Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2012 | 3 |
2013 | 1 |
2015 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.
J Cyst Fibros. 2012 Sep;11(5):446-53. doi: 10.1016/j.jcf.2012.04.003. Epub 2012 May 1.
J Cyst Fibros. 2012.
PMID: 22554417
Free PMC article.
Clinical Trial.
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.
Cogen J, et al.
Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.
Pediatr Pulmonol. 2015.
PMID: 26061914
Free PMC article.
Item in Clipboard
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators.
Mayer-Hamblett N, et al.
Pediatr Pulmonol. 2012 Feb;47(2):125-34. doi: 10.1002/ppul.21525. Epub 2011 Aug 9.
Pediatr Pulmonol. 2012.
PMID: 21830317
Free PMC article.
Clinical Trial.
Item in Clipboard
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators.
Mayer-Hamblett N, et al.
Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.
Pediatr Pulmonol. 2013.
PMID: 23818295
Free PMC article.
Clinical Trial.
Item in Clipboard
Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
Sanders DB, Emerson J, Ren CL, Schechter MS, Gibson RL, Morgan W, Rosenfeld M; EPIC Study Group.
Sanders DB, et al.
Ann Am Thorac Soc. 2015 Aug;12(8):1170-6. doi: 10.1513/AnnalsATS.201504-198OC.
Ann Am Thorac Soc. 2015.
PMID: 26288390
Free PMC article.
Clinical Trial.
Item in Clipboard
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW; Early Pseudomonas Infection Control (EPIC) Investigators.
Treggiari MM, et al.
Arch Pediatr Adolesc Med. 2011 Sep;165(9):847-56. doi: 10.1001/archpediatrics.2011.136.
Arch Pediatr Adolesc Med. 2011.
PMID: 21893650
Free PMC article.
Clinical Trial.
Item in Clipboard
Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group.
Rosenfeld M, et al.
JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.
JAMA. 2012.
PMID: 22610452
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite